Claire Catherinet

Claire is a Senior Associate in the Sofinnova Crossover Strategy. She joined us in February 2021 as an analyst. Prior to joining Sofinnova, Claire was a Life Sciences analyst at Andera Partners, where she identified and invested in biotech and medtech companies.

Claire has a PhD in Hemato-Oncology from Paris Diderot University, which she carried out at the Institut Curie, working on elucidating signaling pathways involved in the activity of leukemic-initiating cells in T cell acute lymphoblastic leukemia (T-ALL).

She also holds an MSc from the French engineering school Agrocampus Ouest and a degree in Biopharmaceutical Management from ESCP Business School. Her research has been published in journals such as Nature Communications and Cancer Cell.